An antibody reactivity-based assay for diagnosis of invasive candidiasis using protein array

International Journal of Immunopathology and Pharmacology

Volumn 27, Issue 3, 2014, Pages 403-412

  Ardizzoni, A ^a   Posteraro, B ^b   Baschieri, M C ^a   Bugli, F ^b   Saez Roson A ^c   Manca, L ^a   Cacaci, M ^b   Paroni Sterbini, F ^b   De Waure, C ^b   Sevilla, M J ^c   Peppoloni, S ^a   Sanguinetti, M ^b   Moragues, M D ^c   Blasi, E ^a,d  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^d Istituti Biologici 2 piano   (Italy)

Author keywords

Antibodies; Antigens; Candida albicans; Invasive candidiasis (IC); Patients; Protein microarrays; Serodiagnosis

Indexed keywords

ADHL PROTEIN; ALS3 PROTEIN; BGI2 PROTEIN; ENOL PROTEIN; FBAL PROTEIN; FUNGAL PROTEIN; GRP2 PROTEIN; HSP90 PROTEIN; HWPL PROTEIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; PDCLL PROTEIN; PGKL PROTEIN; RECOMBINANT ANTIGEN; UNCLASSIFIED DRUG; FUNGUS ANTIBODY; RECOMBINANT PROTEIN;

ANTIBODY DETECTION; ANTIBODY RESPONSE; AREA UNDER THE CURVE; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; HUMAN; IMMUNOASSAY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOREACTIVITY; INVASIVE CANDIDIASIS; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; PROTEIN MICROARRAY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; BLOOD; IMMUNOLOGY; METHODOLOGY;

ANTIBODIES, FUNGAL; CANDIDIASIS, INVASIVE; FUNGAL PROTEINS; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN G; PROTEIN ARRAY ANALYSIS; RECOMBINANT PROTEINS;

EID: 84908451338     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201402700310     Document Type: Article

References (26)

1. Arendrup MC. Epidemiology of invasive candidiasis. Curr Opin Crit Care 2011; 16:445-52.
2. Azie N, Neofytos D, Pfaller M, Meier-Kriesche HU, Quan SP, Horn D. The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012. Diagn Microbiol Infect Dis 2012; 73:293-300.
3. Bassetti M, Molinari, MP, Mussap M, Viscoli C, Righi E. Candidaemia in internal medicine departments: The burden of a rising problem. Clin Microbiol Infect 2013; 19:E281-4.
4. Ullmann AJ, Akova M, Herbrecht R, et al. ESCMID∗ guideline for the diagnosis and management of Candida diseases 2012: Adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT). Clin Microbiol Infect 2012; 18:53-67.
5. Ostrosky-Zeichner L. Invasive mycoses: diagnostic challenges. Am J Med 2012; 125:S14-S24.
6. Mikulska M, Calandra T, Sanguinetti M, Poulain D, Viscoli C: The Third European Conference on Infections in Leukemia Group. The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia. Crit Care 2010; 14:R222.
7. Nguyen MH, Wissel MC, Shields RK, et al. Performance of Candida real-time polymerase chain reaction, (i-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis. Clin Infect Dis 2012; 54:1240-48.
8. Karageorgopoulos DE, Vouloumanou EK, Ntziora F, Michalopoulos A, Rafailidis PI, Falagas ME. (3-D- glucan assay for the diagnosis of invasive fungal infections: A meta-analysis. Clin Infect Dis 2011; 52:750-70.
9. Mokaddas E, Khan ZU, Ahmad S, Nampoory MR, Burhamah M. Value of (l-3)-P-D-glucan, Candida mannan and Candida DNA detection in the diagnosis of candidaemia. Clin Microbiol Infect 2011; 17:1549- 53.
10. Arendrup MC, Bergmann OJ, Larsson L, Nielsen HV, Jarlov JO, Christensson B. Detection of candidaemia in patients with and without underlying haematological disease. Clin Microbiol Infect 2010; 16:855-62.
11. Paramythiotou E, Frantzeskaki F, Flevari A, Armaganidis A, Dimopoulos G. Invasive fungal infections in the ICU: how to approach, how to treat. Molecules 2014; 19:1085-119.
12. Lain A, Elguezabal N, Brena S, Garda-Ruiz JC, Del-Palacio A, Moragues MD, Ponton J. Diagnosis of invasive candidiasis by enzyme-linked immunosorbent assay using the N-terminal fragment of Candida albicans hyphal wall protein 1. BMC Microbiol 2007; 7:35.
13. Lain A, Moragues MD, Garcia-Ruiz JC, Mendoza J, Camacho A, Del Palacio A, Ponton J. Evaluation of a novel enzyme-linked immunosorbent assay to detect immunoglobulin G antibody to enolase for serodiagnosis of invasive candidiasis. Clin Vaccine Immunol 2007; 14:318-9.
14. Lain A, Elguezabal N, Amutio E, Fernandez de Larrinoa I, Moragues MD, Ponton J. Use of recombinant antigens for the diagnosis of invasive candidiasis. Clin Dev Immunol 2008; 2008:721950.
15. Clancy CJ, Nguyen ML, Cheng S, et al. Immunoglobulin G responses to a panel of Candida albicans antigens as accurate and early markers for the presence of systemic candidiasis. J Clin Microbiol 2008;46:1647-54.
16. Ardizzoni A, Capuccini B, Baschieri MC, et al. A protein microarray immunoassay for the serological evaluation of the antibody response in vertically transmitted infections. Eur J Clin Microbiol Infect Dis 2009; 28:1067-75.
17. Burbelo PD, Ching KH, Bush ER, Han BL, Iadarola MJ. Antibody-profiling technologies for studying humoral responses to infectious agents. Expert Rev Vaccines 2010; 9:567-78.
18. Ardizzoni A, Baschieri MC, Manca L, et al. The protein "mycoarray": A novel serological assay for the laboratory diagnosis of primitive endemic mycoses. New Microbiol 2011; 34:307-16.
19. De-Carolis E, Posteraro B, Florio AR, et al. Analysis of heat-induced changes in protein expression of Stenotrophomonas maltophilia K279a reveals a role for GroEL in the host-temperature adaptation. Int J Med Microbiol 2011; 301:273-81.
20. Deeks JJ. Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests. BMJ 2001; 323:157-62.
21. Pitarch A, Abian J, Carrascal M, Sanchez M, Nombela C, Gil C. Proteomics-based identification of novel Candida albicans antigens for diagnosis of systemic candidiasis in patients with underlying hematological malignancies. Proteomics 2004; 4:3084-106.
22. Pitarch A, Jimenez A, Nombela C, Gil C. Decoding serological response to Candida cell wall immunome into novel diagnostic, prognostic, and therapeutic candidates for systemic candidiasis by proteomic and bioinformatic analyses. Mol Cell Proteomics 2006; 5:79-96.
23. Pitarch A, Jimenez A, Nombela C, Gil C. Serological proteome analysis to identify systemic candidiasis patients in the intensive care unit: Analytical, diagnostic and prognostic validation of anti-Candida enolase antibodies on quantitative clinical platforms. Proteomics Clin Appl 2008; 2:596-618.
24. Mochon AB, Jin Y, Kayala MA, et al. Serological profiling of a Candida albicans protein microarray reveals permanent host-pathogen interplay and stage-specific responses during candidemia. PLoS Pathog 2010; 6:e1000827.
25. Burt ET, Daly R, Hoganson D, Tsirulnikov Y, Essmann M, Larsen B. Isolation and partial characterization of Hsp90 from Candida albicans. Ann Clin Lab Sci 2003; 33:86-93.
26. Pitarch A, Nombela C, Gil C. Prediction of the clinical outcome in invasive candidiasis patients based on molecular fingerprints of five anti-Candida antibodies in serum. Mol Cell Proteomics 2011; 10:M 110.004010.